Alden Bahr, MD
General Practice · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Peninsula Ophthalmology Group Inc · 8 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bahr’s office at (650) 697-3200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A186484 · Current
Licensed to practise in California · since 2023 · expires 2027-05-31 · Mcgovern Medical School at the University of Texas Health Science Center at Houston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$96,325
Medicare paid this office $96,325 for 431 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 147 | $16,914 | $89 |
| Removal of cataract with insertion of prosthetic lens | 21 | $16,010 | $552 |
| Established patient complete exam of visual system | 94 | $11,854 | $120 |
| Return visit (30+ min) | 87 | $11,496 | $126 |
| Short return visit (20+ min) | 78 | $9,275 | $90 |
See all 14 services
| Established patient problem focused exam of visual system | 147 | $16,914 | $89 |
| Removal of cataract with insertion of prosthetic lens | 21 | $16,010 | $552 |
| Established patient complete exam of visual system | 94 | $11,854 | $120 |
| Return visit (30+ min) | 87 | $11,496 | $126 |
| Short return visit (20+ min) | 78 | $9,275 | $90 |
| New patient complete exam of visual system | 51 | $6,657 | $131 |
| New patient visit (45+ min) | 23 | $3,340 | $145 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 181 | $3,266 | $15 |
| Exam of visual field with extended testing | 44 | $2,878 | $64 |
| New patient visit (30+ min) | 16 | $1,804 | $113 |
| New patient problem focused exam of visual system | 21 | $1,495 | $71 |
| Imaging of optic nerve | 39 | $1,312 | $33 |
| Measurement of corneal curvature and depth of eye | 21 | $1,017 | $42 |
| Imaging of retina | 22 | $842 | $38 |
Procedures Medicare counted
| Cataract surgery | 78 | More than 71% of doctors who do this |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | – | 71 | 58 | 29 |
| Removal of recurring cataract in lens capsule using a laser | – | 24 | – | – |
| Complex removal of cataract with insertion of prosthetic lens | – | 22 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
431 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 62% · Also on Medicaid 7% · Health risk score 1.07. At or below the middle of the specialty; the typical general practice clinician is at 1.33.
Conditions among them: High blood pressure 69% · Diabetes 26% · Chronic kidney disease 23% · Coronary heart disease 18% · Depression 15% · Cancer 14% · Atrial fibrillation 14% · Heart failure 12% · COPD 7% · Stroke 7% · Dementia 5%.
The office billed $262,813, Medicare allowed $126,385 and paid $96,325; for 1,015 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 431 | 1,015 | 76 | 1.07 | $262,813 | $96,325 |
| 2023 | 548 | 1,023 | 75 | 0.97 | $324,528 | $88,648 |
| 2022 | 872 | 1,968 | 75 | 1.03 | $567,706 | $161,411 |
| 2021 | 285 | 531 | 74 | 1.02 | $144,140 | $48,069 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Removal of cataract with insertion of prosthetic lens | 37 | $24,368 | $420 |
| Established patient complete exam of visual system | 227 | $17,294 | $76 |
| New patient complete exam of visual system | 119 | $10,648 | $89 |
| Established patient problem focused exam of visual system | 72 | $6,294 | $75 |
| Short return visit (20+ min) | 81 | $4,796 | $53 |
| Return visit (30+ min) | 60 | $4,405 | $69 |
| New patient visit (45+ min) | 33 | $2,687 | $81 |
| Measurement of corneal curvature and depth of eye | 46 | $1,945 | $27 |
| Exam of visual field with extended testing | 43 | $1,785 | $41 |
| Imaging of retina | 60 | $1,644 | $25 |
| Imaging of optic nerve | 75 | $1,538 | $21 |
| Photography of the retina | 15 | $431 | $29 |
| Ultrasound scan of cornea to determine thickness | 20 | $127 | $6 |
2022: 18 services
| Removal of cataract with insertion of prosthetic lens | 50 | $30,064 | $423 |
| Established patient complete exam of visual system | 349 | $28,772 | $79 |
| New patient complete exam of visual system | 305 | $27,592 | $90 |
| Complex removal of cataract with insertion of prosthetic lens | 19 | $12,897 | $586 |
| Short return visit (20+ min) | 142 | $12,005 | $70 |
| Established patient problem focused exam of visual system | 151 | $11,160 | $59 |
| New patient visit (45+ min) | 64 | $6,602 | $103 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $6,128 | $255 |
| Return visit (30+ min) | 50 | $4,423 | $85 |
| Exam of visual field with extended testing | 82 | $4,082 | $46 |
| Imaging of retina | 122 | $3,622 | $27 |
| Measurement of corneal curvature and depth of eye | 68 | $3,252 | $32 |
| Imaging of optic nerve | 132 | $3,248 | $24 |
| New patient problem focused exam of visual system | 20 | $1,168 | $58 |
| Microfluid analysis of tears | 26 | $1,156 | $22 |
| Photography of the retina | 35 | $863 | $23 |
| Ultrasound scan of cornea to determine thickness | 57 | $382 | $7 |
| Exam of the internal drainage system of eye | 14 | $246 | $18 |
2021: 8 services
| Established patient complete exam of visual system | 143 | $14,842 | $100 |
| New patient complete exam of visual system | 79 | $8,945 | $113 |
| Established patient problem focused exam of visual system | 64 | $5,293 | $73 |
| Return visit (30+ min) | 16 | $1,495 | $93 |
| Imaging of retina | 38 | $1,246 | $33 |
| Imaging of optic nerve | 41 | $1,225 | $30 |
| Measurement of corneal curvature and depth of eye | 21 | $1,149 | $44 |
| Ultrasound scan of cornea to determine thickness | 18 | $159 | $9 |
Medicaid work
$5,047 in 2023
Medicaid paid $5,047 for 79 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 43 | $3,614 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 18 | $1,216 |
| DETERMINATION REFRACTIVE STATE | 18 | $217 |
| 2023 | 79 | 3 | 18 | $5,047 |
| 2022 | 175 | 2 | 22 | $14,482 |
See the largest Medicaid services in earlier years
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 147 | $14,130 |
| DETERMINATION REFRACTIVE STATE | 28 | $353 |
Drugs they prescribed that Part D paid
$52,320
Pharmacies billed $52,320 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 615) in 2024. At or below the middle of the specialty; the typical general practice clinician is at 0%.
398 generic and 217 brand-name prescriptions · $52,320 in drug cost · 23 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 11 | $11,931 | $1,085 |
| Brimonidine | 22 | $3,479 | $158 |
| Prednisolone Acetate | 81 | $2,308 | $28 |
| Timolol Maleate | 52 | $1,523 | $29 |
| Neomycin-Polymyxin-Dexameth | 82 | $1,115 | $14 |
See all 13 drugs
| Restasis | 11 | $11,931 | $1,085 |
| Brimonidine | 22 | $3,479 | $158 |
| Prednisolone Acetate | 81 | $2,308 | $28 |
| Timolol Maleate | 52 | $1,523 | $29 |
| Neomycin-Polymyxin-Dexameth | 82 | $1,115 | $14 |
| Latanoprost | 89 | $1,022 | $11 |
| Tobramycin-Dexamethasone | 29 | $930 | $32 |
| Fluorometholone | 19 | $871 | $46 |
| Ketorolac Tromethamine | 48 | $714 | $15 |
| Ofloxacin | 51 | $525 | $10 |
| Dorzolamide-Timolol | 22 | $294 | $13 |
| Erythromycin | 15 | $137 | $9 |
| Azithromycin | 21 | $61 | $3 |
Year by year
| 2024 | 615 | 245 | 0% (0) | 35% | $52,320 |
| 2023 | 627 | 206 | 0% (0) | 29% | $83,665 |
| 2022 | 804 | 245 | 0% (0) | 34% | $68,770 |
| 2021 | 257 | 95 | None | 21% | $14,701 |
| 2020 | 93 | 41 | None | 15% | $4,162 |
| 2019 | 402 | 132 | None | 25% | $25,240 |
| 2018 | 147 | 77 | None | 31% | $13,047 |
| 2017 | 11 | None | None | None | $860 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Cequa | 13 | $8,159 | $628 |
| Prednisolone Acetate | 88 | $4,489 | $51 |
| Latanoprost | 113 | $3,134 | $28 |
| Timolol Maleate | 48 | $2,605 | $54 |
| Moxifloxacin | 72 | $2,544 | $35 |
| Dorzolamide-Timolol | 41 | $1,786 | $44 |
| Ketorolac Tromethamine | 71 | $1,320 | $19 |
| Neomycin-Polymyxin-Dexameth | 35 | $431 | $12 |
| Brimonidine | 16 | $414 | $26 |
| Doxycycline Hyclate | 17 | $267 | $16 |
| Erythromycin | 15 | $148 | $10 |
2022: 13 drugs
| Xiidra | 17 | $15,682 | $922 |
| Prednisolone Acetate | 149 | $7,026 | $47 |
| Brinzolamide | 15 | $6,888 | $459 |
| Moxifloxacin | 114 | $3,739 | $33 |
| Ketorolac Tromethamine | 116 | $2,416 | $21 |
| Latanoprost | 112 | $2,100 | $19 |
| Dorzolamide-Timolol | 33 | $1,821 | $55 |
| Neomycin-Polymyxin-Dexameth | 44 | $595 | $14 |
| Timolol Maleate | 52 | $560 | $11 |
| Doxycycline Hyclate | 21 | $497 | $24 |
| Ofloxacin | 12 | $242 | $20 |
| Erythromycin | 19 | $194 | $10 |
| Brimonidine | 11 | $182 | $17 |
2021: 7 drugs
| Timolol Maleate | 13 | $3,644 | $280 |
| Prednisolone Acetate | 40 | $1,472 | $37 |
| Dorzolamide-Timolol | 46 | $1,197 | $26 |
| Moxifloxacin | 23 | $934 | $41 |
| Latanoprost | 39 | $481 | $12 |
| Ketorolac Tromethamine | 15 | $342 | $23 |
| Erythromycin | 22 | $232 | $11 |
2020: 3 drugs
| Prednisolone Acetate | 11 | $395 | $36 |
| Latanoprost | 26 | $236 | $9 |
| Brimonidine | 13 | $69 | $5 |
2019: 9 drugs
| Dorzolamide-Timolol | 48 | $1,736 | $36 |
| Prednisolone Acetate | 30 | $1,268 | $42 |
| Latanoprost | 89 | $1,253 | $14 |
| Doxycycline Hyclate | 19 | $878 | $46 |
| Brimonidine | 47 | $713 | $15 |
| Timolol Maleate | 20 | $652 | $33 |
| Moxifloxacin | 12 | $569 | $47 |
| Erythromycin | 36 | $440 | $12 |
| Dorzolamide | 11 | $330 | $30 |
2018: 1 drug
| Latanoprost | 29 | $344 | $12 |
Money from drug and device companies
$61 in 2024
| 2024 | 3 | 3 | None | $61 |
| 2023 | 1 | 4 | None | $206 |
| 2022 | 1 | 2 | None | $45 |
| 2021 | 2 | 4 | None | $71 |
| 2020 | 1 | 2 | None | $45 |
| 2019 | 2 | 3 | None | $246 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Vyzulta | $21 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $21 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $19 | 1 payment
|
See all 3 published payments
| Bausch & Lomb Americas | Meals · 2024-09-25 | Vyzulta | $21 |
| Johnson & Johnson Surgical Vision | Meals · 2024-09-16 | Tecnis Iol | $19 |
| Oyster Point Pharma | Meals · 2024-04-30 | Tyrvaya | $21 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $206
| Alcon Vision | Clareon | $206 | 4 payments
|
2022: $45
| Alcon Vision | Acrysof Iq Panoptix Uv Iol | $45 | 2 payments
|
2021: $71
| Allergan | Durysta | $41 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $30 | 2 payments
|
2020: $45
| Alcon Vision | Centurion | $45 | 2 payments
|
2019: $246
| Allergan | Xen | $223 | 2 payments
|
| Alcon Vision | Centurion | $23 | 1 payment
|
Professional record
- NPI
- 1104356120
- Licence
- CA A186484, VA 0101272725California A186484: Current · expires 2027-05-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); General practice (208D00000X)
- Mailing address
- 1720 El Camino Real Ste 225, Burlingame, CA, 94010
- NPI first listed
- 2017-06-13
- NPI last updated
- 2023-07-10
- NPI record certified
- 2023-07-10
This is when the NPI record was last certified, not a medical board exam.